Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Immunomodulatory effect of procainamide in man. Inhibition of human suppressor T-cell activity in vitro.
T Ochi, … , P E Lipsky, M Ziff
T Ochi, … , P E Lipsky, M Ziff
Published January 1, 1983
Citation Information: J Clin Invest. 1983;71(1):36-45. https://doi.org/10.1172/JCI110749.
View: Text | PDF
Research Article

Immunomodulatory effect of procainamide in man. Inhibition of human suppressor T-cell activity in vitro.

  • Text
  • PDF
Abstract

Procainamide (PA) induces the production of a number of autoantibodies in a high proportion of treated individuals and in some a syndrome closely resembling systemic lupus erythematosus. The mechanism underlying this action of PA is unclear. To examine the possibility that PA might induce autoantibody formation by altering normal immunoregulatory mechanisms, the action of this drug on an in vitro model of antibody formation in man was examined. PA was found to augment the generation of immunoglobulin-secreting cells (ISC) from human peripheral blood mononuclear cells (PBM) in response to pokeweed mitogen but had no effect on pokeweed mitogen-induced tritiated thymidine incorporation. When purified populations of B and T cells were used, PA enhanced the generation of ISC in B-cell cultures supported by untreated T cells but not by T cells treated with mitomycin C. These results indicate that PA augmented B-cell responses by inhibiting suppressor T-cell activity and not by augmenting helper T-cell or B-cell function. N-Acetyl-procainamide had no effect on the generation of ISC in this system. The effect of PA on concanavalin A (Con A)-induced suppressor cell activity was also examined to determine whether PA altered the generation or expression of suppressor T-cell function. PBM were cultured with 30 microgram/ml of Con A for 48 h to generate suppressor cells. When these were co-cultured with fresh PBM, the number of ISC generated was decreased by 58.1 +/- 3.4% (mean +/- SEM, n = 6). Cells that had been similarly incubated without Con A were not inhibitory. The addition of PA to the Con A-stimulated cultures inhibited the generation of suppressor cells as indicated by the fact that the response of fresh cells co-cultured with the Con A-stimulated cells was diminished by only 27.2 +/- 4.3%. In this system too, N-acetyl-procaimamide had no effect. By contrast, adding PA only to the co-culture of Con A-stimulated cells with fresh PBM had a less marked effect on suppressor cell function. These results indicate that the major action of PA is to inhibit the generation of suppressor T-cell activity. Such an effect may explain the capacity of this agent to induce autoantibody formation in treated individuals.

Authors

T Ochi, E A Goldings, P E Lipsky, M Ziff

×

Total citations by year

Year: 2009 2006 2001 1997 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 Total
Citations: 1 1 1 1 1 2 3 1 3 3 3 3 3 3 7 3 1 40
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (40)

Title and authors Publication Year
Cutaneous histopathology of lupus erythematosus
AN Crowson, CM Magro
Diagnostic Histopathology 2009
Systemic Lupus Erythematosus
M Petri
JCR: Journal of Clinical Rheumatology 2006
The cutaneous pathology of lupus erythematosus: a review
AN Crowson, C Magro
Journal of Cutaneous Pathology 2001
Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy
AN Crowson, CM Magro
Human Pathology 1997
Quinidine-induced rheumatic syndromes
JA Alloway, MP Salata
Seminars in Arthritis and Rheumatism 1995
Effect of a traditional Chinese herbal medicine, Kanzo-bushi-to, on the production of interleukin-4 from a clone of burn-associated CD8+ suppressor T cells
M Kobayashi, T Utsunomiya, DN Herndon, RB Pollard, F Suzuki
Immunology Letters 1994
DRUG-INDUCED LUPUS
RL Yung, BC Richardson
Rheumatic diseases clinics of North America 1994
The effect of methyldopa and procainamide on suppressor cell activity in relation to red cell autoantibody production
G Garratty, P Arndt, HE Prince, IA Shulman
British Journal of Haematology 1993
Drug-Induced Autoimmune Hemolytic Anemia
LD Petz
Transfusion Medicine Reviews 1993
Study of procainamide hapten-specific antibodies in rabbits and humans
LE Adams, SM Roberts, R Donovan-Brand, H Zimmer, EV Hess
International Journal of Immunopharmacology 1993
The Role of Leukocyte-Generated Reactive Metabolites in the Pathogenesis of Ideosyncratic Drug Reactions
JP Uetrecht
Drug Metabolism Reviews 1992
TheIn VltroandIn VivoEffects of 1.1–Dimethylhydrazine (Udmh) On Murine Lymphocyte Subsets and Ia Antigen Expression
DE Frazier, MJ Tarr, RG Olsen
Immunopharmacology and Immunotoxicology 1991
Drug-related lupus syndromes and their relationship to spontaneously occurring systemic lupus erythematosus
D Alarcón-Segovia, A Kraus
Baillière's Clinical Rheumatology 1991
Drug-Related Lupus: Incidence, Mechanisms and Clinical Implications
LE Adams, EV Hess
Drug Safety 1991
Kinetics and pathogenicity of autoantibodies induced by mercuric chloride in the brown Norway rat
CD Pusey, C Bowman, A Morgan, AP Weetman, B Hartley, CM Lockwood
Clinical & Experimental Immunology 1990
Immunotoxic Side-Effects of Drug Therapy:
JA Mitchell, EM Gillam, LA Stanley, E Sim
Drug Safety 1990
Kinetics and pathogenicity of autoantibodies induced by mercuric chloride in the brown Norway rat.
Pusey CD, Bowman C, Morgan A, Weetman AP, Hartley B, Lockwood CM
Clinical & Experimental Immunology 1990
Metabolism of procainamide to the cytotoxic hydroxylamine by neutrophils activated in vitro
RL Rubin, JT Curnutte
Journal of Clinical Investigation 1989
Defective Helper T Cell Function in IgM Rheumatoid Factor Synthesis in Patients with Ankylosing Spondylitis
CL Yu, KL Chang, ST Hong, BN Chiang, SH Han, SR Wang
Scandinavian Journal of Rheumatology 1989
Immunobiology of HLA
B Dupont
1989
Procainamide Induces a Transitory Impairment of b Cell Mitogenesis in Beagle Dogs
SA Mulhern, F Daguillard, CJ Robinson, T Balazs
Drug and Chemical Toxicology 1988
Autoimmunity induced by chemicals
PE Bigazzi
Journal of Toxicology: Clinical Toxicology 1988
POLYMORPHONUCLEAR CELL FACTOR FOUND IN PATIENTS WITH RHEUMATOID ARTHRITIS
S Wakitani, D Sakamuro, T Ochi, H Owaki, M Fujimoto, K Ono
Biomedical Research 1988
Antibodies in procainamide-induced and systemic lupus erythematosus bind the C-terminus of histone 1 (H1)
J Gohill, MJ Fritzler
Molecular Immunology 1987
The origin of autoantibodies
A Schattner
Immunology Letters 1987
Increased presence of common systemic lupus erythematosus (SLE) anti-DNA idiotypes (16/6 Id, 32/15 Id) is induced by procainamide
Y Shoenfeld, Y Vilner, T Reshef, A Klajman, A Skibin, O Kooperman, RC Kennedy
Journal of Clinical Immunology 1987
Specificity of Acebutolol-Induced Antinuclear Antibodies
S Querin, MN Feuillet-Fieux, L Jacob, G Niel, JF Bach
Immunopharmacology and Immunotoxicology 1986
Procainamide elicits a selective autoantibody immune response
RL Rubin, G Reimer, EM McNally, SR Nusinow, RP Searles, EM Tan
Clinical & Experimental Immunology 1986
Haematological Effects of Non-Narcotic Analgesics:
PA Miescher, W Pola
Drugs 1986
Effects of long-term procainamide therapy on immunoglobulin synthesis
CL Yu, M Ziff
Arthritis & Rheumatism 1985
Effects of L-canavanine on t cells may explain the induction of systemic lupus erythematosus by alfalfa
J Alcocer-varela, A Iglesias, L Llorente, D Alarcón-Segovia
Arthritis & Rheumatism 1985
Inhibition of pokeweed mitogen-induced B cell differentiation by compounds containing primary amine or hydrazine groups
G Boccardo, D Drayer, AL Rubin, A Novogrodsky, MM Reidenberg, KH Stenzel
Clinical & Experimental Immunology 1985
Drug-Induced Lupus: Clinical Spectrum and Pathogenesis
JJ Cush, EA Goldings
The American Journal of the Medical Sciences 1985
Drug-induced lupus: Genetic, clinical, and laboratory features
MC Totoritis, RL Rubin
Postgraduate Medicine 1985
PROCAINAMIDE AUGMENTS VACCINATION EFFECT
Y Aoki, N Wakamiya, T Ochi, S Ueda, S Kato, K Ono
Biomedical Research 1985
Immunology of Rheumatic Diseases
S Gupta, N Talal
1985
Captopril and immune regulation
JF Delfraissy, P Galanaud, JF Balavoine, C Wallon, J Dormont
Kidney International 1984
Immunologic and Genetic Factors in Autoimmune Diseases
Y Shoenfeld, RS Schwartz
New England Journal of Medicine 1984
Positive Direct Antiglobulin Tests and Immune Hemolytic Anemia in Patients Receiving Procainamide
S Kleinman, R Nelson, L Smith, D Goldfinger
New England Journal of Medicine 1984
Aromatic amines and the pathogenesis of lupus erythematosus
MM Reidenberg
The American Journal of Medicine 1983

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts